Single-Cell Transcriptome Reveals the Metabolic and Clinical Features of a Highly Malignant Cell Subpopulation in Pancreatic Ductal Adenocarcinoma
Background: Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor with a high mortality rate. PDAC exhibits significant heterogeneity as well as alterations in metabolic pathways that are associated with its malignant progression. In this study, we explored the metabolic and clinical features...
Main Authors: | Yangyang Fang, Shunjie Pei, Kaizhao Huang, Feng Xu, Guangxin Xiang, Linhua Lan, Xiaoqun Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.798165/full |
Similar Items
-
Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
by: Hweixian Leong Penny, et al.
Published: (2021-06-01) -
Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
by: Zongfu Pan, et al.
Published: (2018-12-01) -
WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
by: Yin Wenke, et al.
Published: (2023-01-01) -
Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study
by: Naohiro Kato, et al.
Published: (2023-05-01) -
Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma
by: Wenjing Song, et al.
Published: (2021-06-01)